Literature DB >> 19412694

[Measures to reduce costs for prescriptions in Vienna--preliminary analysis].

Hans Tönies1.   

Abstract

BACKGROUND: To increase the rate of prescriptions for generic drugs in Vienna an information campaign was started in 2004 and quality circles for prescribing doctors were organized. Since the result of this initiative is not yet known publicly this report aims to present a preliminary analysis.
METHODS: The prescription statements kindly provided by the health insurance fund of Vienna could be analysed. Data from the Chamber of Viennese Physicians were used for compiling a report about the quality circles.
RESULTS: A total of 17 quality circles with an average of 15 participants were formed; they met four times yearly. Participants were paid for their attendance. The rate of prescribed generic drugs in Vienna has continuously improved, with the major increase in the first year of the activities. In the year 2006 a rate of over 40% generic prescriptions was reached by 80% of general practitioners.
CONCLUSIONS: This cooperation between the health insurance fund and doctors apparently resulted in both an increase in the rate of generic drugs prescribed and in a good acceptance among physicians.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412694     DOI: 10.1007/s10354-009-0671-y

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  5 in total

1.  [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].

Authors:  Susanne Führlinger
Journal:  Wien Med Wochenschr       Date:  2006-12

2.  [Generics in Austria 2003-2008: an update].

Authors:  Markus Müller
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  Results of a 12-month quality-circle prescribing improvement programme for GPs.

Authors:  Françoise Riou; Christine Piette; Gérard Durand; Jacques Chaperon
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

4.  Switching statins in Norway after new reimbursement policy: a nationwide prescription study.

Authors:  Solveig Sakshaug; Kari Furu; Øystein Karlstad; Marit Rønning; Svetlana Skurtveit
Journal:  Br J Clin Pharmacol       Date:  2007-04-18       Impact factor: 4.335

5.  [Generic drugs: quality, efficacy, safety and interchangeability].

Authors:  Doris Tschabitscher; Peter Platzer; Christoph Baumgärtel; Marcus Müllner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

  5 in total
  1 in total

1.  [Questions and developments in the general medicine specialty].

Authors:  Manfred Maier
Journal:  Wien Med Wochenschr       Date:  2009
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.